Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metastatic Bladder Urothelial Carcinoma × berzosertib × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Metastatic Bladder Urothelial Carcinoma 1

Interventions

pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 berzosertib 1 aldesleukin 1 Platinum 1 Immunoglobulin G 1 Gemcitabine 1 Cyclophosphamide 1 Cisplatin 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02567409 2025-03-03

Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer

National Cancer Institute (NCI)

Phase 2 Completed

87 enrolled 13 charts

Metastatic Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡